LOTUS HORIZON (06063) issues profit warning, expects interim consolidated net loss of approximately HK$2.5 million, turning from profit to loss year-on-year.
LOTUS HORIZON (06063) announced that the Group is expected to record a consolidated net loss of approximately HK$2.5 million for the six months ended September 30, 2026 (the interim period), compared with a consolidated net profit of approximately HK$1.3 million for the six months ended September 30, 2025.
LOTUS HORIZON (06063) announced that the Group is expected to record a consolidated net loss of approximately HK$2.5 million for the six months ended September 30, 2026 (the Interim Period), compared to a consolidated net profit of approximately HK$1.3 million for the six months ended September 30, 2025.
Based on the information currently available, the Board considers that the above turnaround from profit to loss was primarily attributable to the slowdown in construction progress of certain key projects awarded; and the continuous decline in gross profit margins of projects secured over the past 12 months due to intense competition in the Hong Kong market.
Related Articles
ANTENGENE-B (06996) repurchased 107,000 shares on October 28 for approximately HK$303,800.
CSPC PHARMA (01093): CSPC Innovation Pharmaceutical's net profit attributable to shareholders for the first three quarters was RMB1.21 billion.
MNSO (09896) repurchased 100,000 shares on October 28 for approximately HK$1.9187 million.
ANTENGENE-B (06996) repurchased 107,000 shares on October 28 for approximately HK$303,800.
CSPC PHARMA (01093): CSPC Innovation Pharmaceutical's net profit attributable to shareholders for the first three quarters was RMB1.21 billion.
MNSO (09896) repurchased 100,000 shares on October 28 for approximately HK$1.9187 million.
